Medical therapy of diabetic foot infections

Journal of Vascular Surgery

Volumn 52, Issue 3 SUPPL., 2010, Pages 67S-71S

  Joseph, Warren S ^a   Lipsky, Benjamin A ^b  

^a Roxborough Memorial Hospital   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CEFALEXIN; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DICLOXACILLIN; ERTAPENEM; LEVOFLOXACIN; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TIMENTIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; DIABETIC FOOT; DISEASE SEVERITY; EDEMA; ERYTHEMA; HUMAN; LEG AMPUTATION; LIMB SALVAGE; NONHUMAN; PAIN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RATING SCALE; REVIEW; SKIN INDURATION; VASCULAR SURGERY; WOUND INFECTION; COOPERATION; EVIDENCE BASED MEDICINE; INFECTIOUS DISEASE MEDICINE; INTERDISCIPLINARY COMMUNICATION; MEDICAL SOCIETY; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PATIENT CARE; PODIATRY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED STATES; WOUND HEALING;

ANTI-BACTERIAL AGENTS; COMBINED MODALITY THERAPY; COOPERATIVE BEHAVIOR; DIABETIC FOOT; EVIDENCE-BASED MEDICINE; HUMANS; INFECTIOUS DISEASE MEDICINE; INTERDISCIPLINARY COMMUNICATION; PATIENT CARE TEAM; PODIATRY; PRACTICE GUIDELINES AS TOPIC; SEVERITY OF ILLNESS INDEX; SOCIETIES, MEDICAL; TREATMENT OUTCOME; UNITED STATES; VASCULAR SURGICAL PROCEDURES; WOUND HEALING; WOUND INFECTION;

EID: 77956252467     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.06.010     Document Type: Review

References (16)

1. B.A. Lipsky A report from the international consensus on diagnosing and treating the infected diabetic foot Diabetes Metab Res Rev 20 Suppl 1 2004 S68 S77
2. B.A. Lipsky, A.R. Berendt, H.G. Deery, J. Embil, W.S. Joseph, A.W. Karchmer Infectious Disease Society of America Diagnosis and treatment of diabetic foot infections Clin Infect Dis 39 2004 885 910
3. L.A. Lavery, D.G. Armstrong, D.P. Murdoch, E.J. Peters, and B.A. Lipsky Validation of the Infectious Diseases Society of America's diabetic foot infection classification system Clin Infect Dis 44 2007 562 565
4. N. Rao, and B.A. Lipsky Optimising antimicrobial therapy in diabetic foot infections Drugs 67 2007 195 214
5. K. Van Acker, C. De Block, and P. Abrams The choice of diabetic foot ulcer classification in relation to the final outcome Wounds 14 2002 16 25
6. D.G. Armstrong, L.A. Lavery, and L.B. Harkless Validation of a diabetic wound classification system The contribution of depth, infection, and ischemia to risk of amputation Diabetes Care 21 1998 855 859
7. A.R. Berendt, E.J. Peters, K. Bakker, J.M. Embil, M. Eneroth, and R.J. Hinchliffe Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment Diabetes Metab Res Rev 24 Suppl 1 2008 S145 S161
8. J. Teh, T. Berendt, and B.A. Lipsky Rational imaging Investigating suspected bone infection in the diabetic foot BMJ 339 2009 b4690
9. A. Nawaz, D.A. Torigian, E.S. Siegelman, S. Basu, T. Chryssikos, and A. Alavi Diagnostic performance of FDG-PET, MRI, and plain film radiography (PFR) for the diagnosis of osteomyelitis in the diabetic foot Mol Imaging Biol 12 2010 335 342
10. F.L. Bowling, E.B. Jude, and A.J. Boulton MRSA and diabetic foot wounds: contaminating or infecting organisms? Curr Diab Rep 9 2009 440 444
11. C.N. Dang, Y.D. Prasad, A.J. Boulton, and E.B. Jude Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem Diabet Med 20 2003 159 161
12. I.M. Gould Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus Int J Antimicrob Agents 31 Suppl 2 2008 1 9
13. Centers for Disease Control and Prevention (CDC) Vancomycin-resistant Staphylococcus aureusPennsylvania, 2002 MMWR Morb Mortal Wkly Rep 51 2002 902
14. A. Varaiya, J. Dogra, M. Kulkarni, and P. Bhalekar Extended spectrum beta lactamase (ESBL) producing Escherichia coli and klebsiella pneumoniae in diabetic foot infection Indian J Med Microbiol 26 2008 281 282
15. B.A. Lipsky, Y.P. Tabak, R.S. Johannes, L. Vo, L. Hyde, and J.A. Weigelt Skin and soft tissue infections in hospitalised patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost Diabetologia 53 2010 914 923
16. D.P. Nicolau, and G.E. Stein Therapeutic options for diabetic foot infections: a review with an emphasis on tissue penetration characteristics J Am Podiatr Med Assoc 100 2010 52 63